Oncoprotein p28GANK binds to RelA and retains NF-κB in the cytoplasm through nuclear export

被引:47
作者
Chen, Yao [1 ]
Li, Hong Hai [1 ,3 ]
Fu, Jing [1 ]
Wang, Xue Feng [1 ]
Bin Ren, Yi [1 ]
Dong, Li Wei [1 ]
Tang, Shan Hua [1 ]
Liu, Shu Qing [1 ]
Wu, Meng Chao [2 ]
Wang, Hong Yang [1 ,3 ]
机构
[1] Eastern Hepatobiliary Surg Hosp, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China
[2] Eastern Hepatobiliary Surg Hosp, Dept Surg, Shanghai 200438, Peoples R China
[3] Shanghai Jiao Tong Univ, Inst Canc, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China
关键词
p28(GANK); NF-kappa B; CRM-1;
D O I
10.1038/cr.2007.99
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p28(GANK) (also known as PSMD10, p28 and gankyrin) is an ankyrin repeat anti-apoptotic oncoprotein that is commonly overexpressed in hepatocellular carcinomas and increases the degradation of p53 and Rb. NF-kappa B (nuclear factor-kappa B) is known to be sequestered in the cytoplasm by I kappa B (inhibitor of NF-kappa B) proteins [1, 2], but much less is known about the cytoplasmic retention of NF-kappa B by other cellular proteins. Here we show that p28(GANK) inhibits NF-kappa B activity. As a nuclear-cytoplasmic shuttling protein, p28(GANK) directly binds to NF-kappa B/RelA and exports RelA from nucleus through a chromosomal region maintenance-1 (CRM-1) dependent pathway, which results in the cytoplasmic retention of NF-kappa B/RelA. We demonstrate that all the ankyrin repeats of p28(GANK) are required for the interaction with RelA and that the N terminus of p28(GANK), which contains the nuclear export sequence (NES), is responsible for suppressing NF-kappa B/RelA nuclear translocation. These results suggest that overexpression of p28(GANK) prevents the nuclear localization and inhibits the activity of NF-kappa B/RelA.
引用
收藏
页码:1020 / 1029
页数:10
相关论文
共 39 条
[1]   Nuclear factor-κ-B:: The enemy within [J].
Aggarwal, BB .
CANCER CELL, 2004, 6 (03) :203-208
[2]  
ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369
[3]   IκB-NF-κB structures:: At the interface of inflammation control [J].
Baeuerle, PA .
CELL, 1998, 95 (06) :729-731
[4]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[5]   Control of apoptosis by Rel/NF-κB transcription factors [J].
Barkett, M ;
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6910-6924
[6]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[7]   Signaling molecules of the NF-κB pathway shuttle constitutively between cytoplasm and nucleus [J].
Birbach, A ;
Gold, P ;
Binder, BR ;
Hofer, E ;
de Martin, R ;
Schmid, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10842-10851
[8]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[9]   Shaping the nuclear action of NF-κB [J].
Chen, LF ;
Greene, WC .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (05) :392-401
[10]   Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome [J].
Dawson, S ;
Apcher, S ;
Mee, M ;
Higashitsuji, H ;
Baker, R ;
Uhle, S ;
Dubiel, W ;
Fujita, J ;
Mayer, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10893-10902